Jaime Anderson

1.3k total citations
12 papers, 219 citations indexed

About

Jaime Anderson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jaime Anderson has authored 12 papers receiving a total of 219 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Jaime Anderson's work include Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Jaime Anderson is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Jaime Anderson collaborates with scholars based in United States and Finland. Jaime Anderson's co-authors include David Van Wyck, Kevin Johnson, Van Anh Trinh, Jennifer Davis, Michael F. Seldin, Huilin Li, Kari Laiho, J. Tuomilehto, Kevin B. Kim and Wen-Jen Hwu and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Nephrology Dialysis Transplantation.

In The Last Decade

Jaime Anderson

12 papers receiving 209 citations

Peers

Jaime Anderson

HEMAT

MB

ONCOL

GENET

Georgi Manukjan Germany

Marilyn Sánchez-Bonilla United States

Shuqian Xu China

Virginie Helias France

Leandro F. Dalmazzo Brazil

Amritha Varshini Hanasoge Somasundara United States

Christian Reimann Germany

Carine Torset France

Amélie Bonaud France

Céline Bourgne France

Georgi Manukjan Germany

Jaime Anderson

137 ×1.8

HEMAT

88 ×1.7

MB

28 ×0.6

ONCOL

37 ×0.8

GENET

32 ×0.9

GENET

Citations per year, relative to Jaime Anderson Jaime Anderson (= 1×) peers Georgi Manukjan

Countries citing papers authored by Jaime Anderson

Since Specialization

Citations

This map shows the geographic impact of Jaime Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime Anderson more than expected).

Fields of papers citing papers by Jaime Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaime Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime Anderson. The network helps show where Jaime Anderson may publish in the future.

Co-authorship network of co-authors of Jaime Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Jaime Anderson. A scholar is included among the top collaborators of Jaime Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime Anderson. Jaime Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Michaud, Laura Boehnke, et al.. (2019). Women in oncology pharmacy leadership: A white paper. Journal of Oncology Pharmacy Practice. 26(1). 175–186. 5 indexed citations

2.

Patel, Shreyaskumar, Gener Balmes, Jason Joseph, et al.. (2019). A Phase I Study of Percutaneous Oncolytic Rose Bengal Disodium for Metastatic Uveal Melanoma Patients with Hepatic Metastases: A Single-Center Cohort Summary. Annals of Oncology. 30. xi45–xi45. 1 indexed citations

3.

Zobniw, Chrystia M., et al.. (2018). Avelumab: A Review of Its Application in Metastatic Merkel Cell Carcinoma. Annals of Pharmacotherapy. 52(9). 928–935. 12 indexed citations

4.

Glitza, Isabella C., Michelle Rohlfs, Jessie Richard, et al.. (2018). A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD). Annals of Oncology. 29. viii464–viii464. 4 indexed citations

5.

Agliardi, Giulia, Ankit Patel, Adriana Romiti, et al.. (2017). CAR T Cells Combined With PD1 Blockade Promote Long-Term Efficacy in a Mouse Model for High Grade Gliomas. UCL Discovery (University College London). 1 indexed citations

6.

Kim, Dae Won, Jaime Anderson, & Sapna P. Patel. (2016). Immunotherapy for Uveal Melanoma. PubMed. 3(2). 125–135. 3 indexed citations

7.

Anderson, Jaime, et al.. (2015). Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma.. PubMed. 19(106). 393–401. 17 indexed citations

8.

Trinh, Van Anh, Jennifer Davis, Jaime Anderson, & Kevin B. Kim. (2013). Dabrafenib Therapy for Advanced Melanoma. Annals of Pharmacotherapy. 48(4). 519–529. 23 indexed citations

9.

Anderson, Jaime, et al.. (2013). New and emerging therapies for advanced or metastatic soft tissue sarcoma. Journal of Oncology Pharmacy Practice. 20(4). 288–297. 5 indexed citations

10.

Anderson, Jaime, et al.. (2012). Improvement of time to develop treatment plan at a specialized sarcoma center.. Journal of Clinical Oncology. 30(34_suppl). 127–127. 1 indexed citations

11.

Wyck, David Van, Jaime Anderson, & Kevin Johnson. (2004). Labile iron in parenteral iron formulations: a quantitative and comparative study. Nephrology Dialysis Transplantation. 19(3). 561–565. 86 indexed citations

12.

Li, Huilin, et al.. (2000). A simple and accurate method for determination of microsatellite total allele content differences between DNA pools. Human Genetics. 106(2). 218–226. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact